Open Access

Synthesis of a novel p‑hydroxycinnamic amide with anticancer capability and its interaction with human serum albumin

  • Authors:
    • Yuan‑Hong Jiao
    • Fa‑Yan Meng
    • Gui‑Bing Zhu
    • Ling‑Zi Ran
    • Yu‑Feng Jiang
    • Qian Zhang
  • View Affiliations

  • Published online on: December 6, 2018     https://doi.org/10.3892/etm.2018.7060
  • Pages: 1321-1329
  • Copyright: © Jiao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

In the present study, a novel p-hydroxycinnamic amide (E)-3-(4-hydroxyphenyl)-N-(4-(N-(5-meth oxypyrimidin-2-yl)-sulfamoyl)phenyl)acrylamide (HMSP) was synthesized and confirmed. In vitro cytotoxic assays indicated that HMSP was able to inhibit the proliferation of various cancer cell lines. The interaction between HMSP and human serum albumin (HSA) was examined by fluorescence, UV‑Vis and circular dichroism (CD) spectra, in addition to molecular simulation. The fluorescence and UV‑Vis spectra data indicated that the binding of HMSP with HSA was a static process. According to the fluorescence quenching calculation, the corresponding thermodynamic parameters, bimolecular quenching rate constant and apparent quenching constants were calculated. Van der Walls forces and hydrogen bonds were vital in the binding of HMSP on HSA. The distances between HSA and its derivatives were obtained. Furthermore, competitive experiments and molecular modeling results suggested that the binding of the compound on HSA mainly occurred in site I (sub‑domain IIA). Changes in HSA conformation were observed from synchronous fluorescence and CD spectra, which were further investigated by molecular dynamic simulations.
View Figures
View References

Related Articles

Journal Cover

February-2019
Volume 17 Issue 2

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Jiao YH, Meng FY, Zhu GB, Ran LZ, Jiang YF and Zhang Q: Synthesis of a novel p‑hydroxycinnamic amide with anticancer capability and its interaction with human serum albumin. Exp Ther Med 17: 1321-1329, 2019
APA
Jiao, Y., Meng, F., Zhu, G., Ran, L., Jiang, Y., & Zhang, Q. (2019). Synthesis of a novel p‑hydroxycinnamic amide with anticancer capability and its interaction with human serum albumin. Experimental and Therapeutic Medicine, 17, 1321-1329. https://doi.org/10.3892/etm.2018.7060
MLA
Jiao, Y., Meng, F., Zhu, G., Ran, L., Jiang, Y., Zhang, Q."Synthesis of a novel p‑hydroxycinnamic amide with anticancer capability and its interaction with human serum albumin". Experimental and Therapeutic Medicine 17.2 (2019): 1321-1329.
Chicago
Jiao, Y., Meng, F., Zhu, G., Ran, L., Jiang, Y., Zhang, Q."Synthesis of a novel p‑hydroxycinnamic amide with anticancer capability and its interaction with human serum albumin". Experimental and Therapeutic Medicine 17, no. 2 (2019): 1321-1329. https://doi.org/10.3892/etm.2018.7060